Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer

Clinical trial NCT06312670 · COMPLETED

Trial details

NCT number: NCT06312670
Sponsor: Pedro Barata, MD, MSc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Prostate Cancer Prostate Adenocarcinoma

Start date: 2024-05-16
Primary completion: 2025-01-09
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.